Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of antidotes to coagulation inhibitors indicated in the prevention or treatment of thromboembolic pathologies

Use of antidotes to coagulation inhibitors indicated in the prevention or treatment of thromboembolic pathologies

US Patent 9700603 · Granted Jul 11, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Factor X mutants2019
VIII factors for the treatment of type A hemophilia2014
Modified factor VIII cDNA2004
Modified factor VIII cDNA and its use for the production of factor VIII2004
DNA-constructs of blood clotting factors and P-Selectin2002
Modified factor VIII cDNA2001